Extracorporeal Enzyme Reactors for Depletion of Phenylalanine in Phenylketonuria

  1. CLARA M. AMBRUS, M.D., Ph.D.;
  2. SIDNEY ANTHONE, M.D.;
  3. CSABA HORVATH, Ph.D.;
  4. KRISHNA KALGHATGI, Ph.D.;
  5. AMOL S. LELE, M.D.;
  6. GIORGINA EAPEN, M.D.;
  7. JULIAN L. AMBRUS, M.D., Ph.D.;
  8. A. JOHN RYAN, M.D.; and
  9. PHILIP LI, Ph.D.
  1. Buffalo and West Seneca, New York; and New Haven, Connecticut

    Abstract

    Multitubular enzyme reactors with immobilized enzymes were developed to achieve depletion of circulating substrate by extracorporeal means. To act as prototypes, reactors were prepared with immobilized L-phenylalanine ammonia-lyase, an enzyme that metabolizes phenylalanine to trans-cinnamic acid and ammonia without the need for a coenzyme. We report the first application of phenylalanine ammonia-lyase reactors in an extracorporeal circulation system in a patient with phenylketonuria. A phenylalanine level of 1.82 mmol/L (for the last 6 years) decreased to 1.24 mmol/L after 5.5. hours of treatment, without the enzyme entering the circulation. Total phenylalanine depletion from blood and tissue stores was estimated at 1800 mg. The hemodialysis-like procedure proved to be without side effects, specific for phenylalanine, and suitable in the management of pregnant women with phenylketonuria and late-onset hyperphenylalaninemia. The extracorporeal use of enzyme reactors for temporary enzyme replacement represents a new, safe, and effective therapeutic modality.

    Article and Author Information

    • ▸From the Departments of Gynecology-Obstetrics, Surgery, and Medicine and Pediatrics, University of Buffalo (SUNY) School of Medicine, the Roswell Park Memorial Institute and Children's Hospital of Buffalo, Buffalo, New York; the West Seneca Developmental Center, West Seneca, New York; and the Department of Chemical Engineering, Yale University, New Haven, Connecticut.

    • Grant support: in part by grant 6-355 from the March of Dimes, grant FD-R000051 from the Orphan Grant Division of the Food and Drug Administration, and a grant from the Rich Foundation, Buffalo, New York.

    • ▸Requests for reprints should be addressed to Clara M. Ambrus, M.D.; Department of Gynecology-Obstetrics, Children's Hospital of Buffalo, 140 Hodge Ave.; Buffalo, NY 14222.

    « Previous | Next Article »Table of Contents